LGC tightens price, accelerates deadline on KKR buyout loan
LGC, the UK life sciences company being bought by KKR, has tightened price guidance on its €350m euro term loan ‘B’ and accelerated its deadline.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: